1-({2-[1-(14-carboxy-3,6,9,12-tetraoxatetradecan-1-yl)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}oxy)-3,6,9,12-tetraoxapentadecan-15-oic acid
Structure Info
- Chemspace ID
- CSSB14813040345 (In-Stock Building Blocks)
- IUPAC Name
- 1-({2-[1-(14-carboxy-3,6,9,12-tetraoxatetradecan-1-yl)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}oxy)-3,6,9,12-tetraoxapentadecan-15-oic acid
- Mol formula
- C35H50N2O17
- Mol weight
- 771 Da
- Catalog Number(s)
- 198599, BP-29724
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -0.86
- Heavy atoms count
- 54
- Rotatable bond count
- 32
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.657
- Polar surface area (Å)
- 232
- Hydrogen bond acceptors count
- 17
- Hydrogen bond donors count
- 2
- Zoom the structure
- CSSB14813040345
Items Overall 3 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Broadpharm | 20 days | United States To: | 98 | 100 mg | 473.00 | |
| Broadpharm | 20 days | United States To: | 98 | 250 mg | 935.00 | |
| Broadpharm | 20 days | United States To: | 98 | 500 mg | 1,650.00 | |
Description: D-acid-PEG4-Thalidomide-5-(PEG4-acid) | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of 6-({2-[1-(5-carboxypentyl)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}oxy)hexanoic acid - CSSB20504686096](/st/structure/200/e2ff4b052b471145d368dd82e324db5f/OC%2528%253DO%2529CCCCCOC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529N%2528CCCCCC%2528O%2529%253DO%2529C1%253DO%2529C2%253DO.png)
![Chemical structure of 3-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}ethoxy)ethoxy]propanoic acid - CSSB06645075048](/st/structure/200/fed3f41b76f7efd8347b98d4029bb008/OC%2528%253DO%2529CCOCCOCCOc1cccc2C%2528%253DO%2529N%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529c12.png)
![Chemical structure of 3-{2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}ethoxy)ethoxy]ethoxy}propanoic acid - CSSB06645075037](/st/structure/200/65a1e8f50b62e4c88759591b1e67a0be/OC%2528%253DO%2529CCOCCOCCOCCOc1cccc2C%2528%253DO%2529N%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529c12.png)
![Chemical structure of 1-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}-3,6,9,12-tetraoxapentadecan-15-oic acid - CSSB03436546869](/st/structure/200/0db49acdb702bbd1f8c70730c95560ce/OC%2528%253DO%2529CCOCCOCCOCCOCCOC1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
![Chemical structure of 1-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid - CSSB06741709242](/st/structure/200/6a2fb85a186806df472394530a23a442/OC%2528%253DO%2529CCOCCOCCOCCOCCOCCOCCOc1cccc2C%2528%253DO%2529N%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529c12.png)
![Chemical structure of 2-{[2-(1-methyl-2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetic acid - CSSB02495349903](/st/structure/200/e9f3a1c40c0171face5f88b217a3de89/CN1C%2528%253DO%2529CCC%2528N2C%2528%253DO%2529C3%253DCC%253DCC%2528OCC%2528O%2529%253DO%2529%253DC3C2%253DO%2529C1%253DO.png)
![Chemical structure of 3-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}propanoic acid - CSSB06256034701](/st/structure/200/5fee285bc04e3e3391968855dd1ebfa0/OC%2528%253DO%2529CCOc1cccc2C%2528%253DO%2529N%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529c12.png)
